Screener
Collegium Pharmaceutical, Inc. COLL Segment — Medical expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept coll:MedicalExpenses.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Intangible asset amortization | 62,953 | 55,473 | 118,426 | 110,946 |
| Commercial expenses | 46,403 | 44,115 | 93,760 | 84,908 |
| Corporate expenses | 12,163 | 9,801 | 26,703 | 23,090 |
| Medical expenses | 7,899 | 7,832 | 15,047 | 15,865 |
| Technical operations expenses | 165 | 136 | 415 | 234 |
| Stock-based compensation expense | 14,484 | 10,818 | 25,364 | 22,342 |
| Other segment items(1) | 25,480 | 577 | 31,655 | 2,477 |
| Interest expense | 19,519 | 20,463 | 35,381 | 41,253 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s segment — medical expenses?
- Collegium Pharmaceutical, Inc. (COLL) reported segment — medical expenses of $7.9M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s segment — medical expenses changed year-over-year?
- Collegium Pharmaceutical, Inc.'s segment — medical expenses increased by 0.9% year-over-year, from $7.83M to $7.9M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s segment — medical expenses?
- Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s segment — medical expenses has grown at a 20.5% compound annual growth rate (CAGR), from $16.99M to $29.75M.
- What does segment — medical expenses mean?
- Includes costs associated with medical affairs, clinical support, and scientific communication activities that educate healthcare providers on product safety and efficacy. These expenses are vital for maintaining the clinical credibility and regulatory compliance of the product portfolio.
Ask your AI about Collegium Pharmaceutical, Inc.'s segment — medical expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude